A perspective on cancer cell metastasis

Science

Volumn 331, Issue 6024, 2011, Pages 1559-1564

  Chaffer, Christine L ^a,b   Weinberg, Robert A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; PHYSIOLOGY; TRANSLOCATION; TUMOR;

BREAST CANCER; CANCER CELL; CANCER INVASION; CANCER STEM CELL; CANCER SURVIVAL; CELL HOMING; CELL PROLIFERATION; COLORECTAL CARCINOMA; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; INFLAMMATORY CELL; LUNG CANCER; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW; STOMACH CANCER; STROMA CELL; TUMOR DIFFERENTIATION; TUMOR MICROENVIRONMENT;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; NEOPLASTIC CELLS, CIRCULATING; NEOPLASTIC STEM CELLS; TUMOR MICROENVIRONMENT;

EID: 79953147370     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1203543     Document Type: Review

References (62)

1. I. J. Fidler, Nat. Rev. Cancer 3, 453 (2003).
2. J. A. Joyce, J. W. Pollard, Nat. Rev. Cancer 9, 239 (2009).
3. D. Hanahan, R. A. Weinberg, Cell 100, 57 (2000).
4. A. F. Chambers, A. C. Groom, I. C. MacDonald, Nat. Rev. Cancer 2, 563 (2002).
5. J. P. Thiery, J. P. Sleeman, Nat. Rev. Mol. Cell Biol. 7, 131 (2006).
6. L. Foulds, Cancer Res. 14, 327 (1954).
7. D. Bonnet, J. E. Dick, Nat. Med. 3, 730 (1997).
8. M. Al-Hajj, M. S. Wicha, A. Benito-Hernandez, S. J. Morrison, M. F. Clarke, Proc. Natl. Acad. Sci. U.S.A. 100, 3983 (2003).
9. L. E. Ailles, I. L. Weissman, Curr. Opin. Biotechnol. 18, 460 (2007).
10. E. Charafe-Jauffret et al., Cancer Res. 69, 1302 (2009).
11. R. Pang et al., Cell Stem Cell 6, 603 (2010).
12. P. Marcato et al., Stem Cells 29, 32 (2011).
13. E. Quintana et al., Nature 456, 593 (2008).
14. K. Ishizawa et al., Cell Stem Cell 7, 279 (2010).
15. J. P. Thiery, H. Acloque, R. Y. Huang, M. A. Nieto, Cell 139, 871 (2009).
16. S. A. Mani et al., Cell 133, 704 (2008).
17. A. P. Morel et al., PLoS ONE 3, e2888 (2008).
18. A. Gal et al., Oncogene 27, 1218 (2008).
19. J. Yang, R. A. Weinberg, Dev. Cell 14, 818 (2008).
20. E. Lim et al.; kConFab, Nat. Med. 15, 907 (2009).
21. A. Prat et al., Breast Cancer Res. 12, R68 (2010).
22. S. Braun et al., N. Engl. J. Med. 353, 793 (2005).
23. K. Pantel, C. Alix-Panabières, S. Riethdorf, Nat. Rev. Clin. Oncol. 6, 339 (2009).
24. S. Meng et al., Clin. Cancer Res. 10, 8152 (2004).
25. E. Camerer et al., Blood 104, 397 (2004).
26. B. Nieswandt, M. Hafner, B. Echtenacher, D. N. Männel, Cancer Res. 59, 1295 (1999).
27. M. Lacroix, Endocr. Relat. Cancer 13, 1033 (2006).
28. K. Pantel, R. H. Brakenhoff, B. Brandt, Nat. Rev. Cancer 8, 329 (2008).
29. M. Mego, S. A. Mani, M. Cristofanilli, Nat. Rev. Clin. Oncol. 7, 693 (2010).
30. S. Ito et al., Int. J. Cancer 93, 212 (2001).
31. C. W. Wong et al., Am. J. Pathol. 161, 749 (2002).
32. E. Sahai, Nat. Rev. Cancer 7, 737 (2007).
33. H. G. Kopp, S. T. Avecilla, A. T. Hooper, S. Rafii, Physiology (Bethesda) 20, 349 (2005).
34. C. Alix-Panabières, S. Riethdorf, K. Pantel, Clin. Cancer Res. 14, 5013 (2008).
35. M. Abdel-Ghany, H. C. Cheng, R. C. Elble, B. U. Pauli, J. Biol. Chem. 276, 25438 (2001).
36. H. Wang et al., J. Cell Biol. 164, 935 (2004).
37. D. M. Brown, E. Ruoslahti, Cancer Cell 5, 365 (2004).
38. K. R. Hess et al., Cancer 106, 1624 (2006).
39. Y. Kang et al., Cancer Cell 3, 537 (2003).
40. A. J. Minn et al., Nature 436, 518 (2005).
41. P. D. Bos et al., Nature 459, 1005 (2009).
42. G. Bloom et al., Am. J. Pathol. 164, 9 (2004).
43. P. J. Campbell et al., Nature 467, 1109 (2010).
44. S. Yachida et al., Nature 467, 1114 (2010).
45. M. Y. Kim et al., Cell 139, 1315 (2009).
46. I. J. Fidler, J. Natl. Cancer Inst. 45, 773 (1970).
47. J. W. Kim et al., Cancer Lett. 213, 203 (2004).
48. K. J. Luzzi et al., Am. J. Pathol. 153, 865 (1998).
49. P. E. Goss, A. F. Chambers, Nat. Rev. Cancer 10, 871 (2010).
50. J. A. Aguirre-Ghiso, Nat. Rev. Cancer 7, 834 (2007).
51. R. N. Kaplan et al., Nature 438, 820 (2005).
52. S. Hiratsuka, A. Watanabe, H. Aburatani, Y. Maru, Nat. Cell Biol. 8, 1369 (2006).
53. S. Y. Kang et al., Proc. Natl. Acad. Sci. U.S.A. 106, 12115 (2009).
54. A. Hirshberg, P. Leibovich, I. Horowitz, A. Buchner, J. Oral Maxillofac. Surg. 51, 1334 (1993).
55. H. F. Dvorak, N. Engl. J. Med. 315, 1650 (1986).
56. G. N. Naumov et al., Breast Cancer Res. Treat. 82, 199 (2003).
57. S. Braun et al., J. Clin. Oncol. 18, 80 (2000).
58. R. J. Weil, D. C. Palmieri, J. L. Bronder, A. M. Stark, P. S. Steeg, Am. J. Pathol. 167, 913 (2005).
59. X. Li et al., J. Natl. Cancer Inst. 100, 672 (2008).
60. E. Buck et al., Mol. Cancer Ther. 6, 532 (2007).
61. C. J. Creighton et al., Proc. Natl. Acad. Sci. U.S.A. 106, 13820 (2009).
62. C.L.C. is supported by the National Health and Medical Research Council of Australia and the Advanced Medical Research Foundation. R.A.W. is supported by the National Cancer Institute, MIT Ludwig Center for Molecular Oncology, and Breast Cancer Research Fund. R.A.W. is a founder and shareholder of Verastem, Inc., a biopharmaceutical company focused on discovering and developing drugs that target cancer stem cells.